文献速递前列腺癌

未接受筛查的老年男性前列腺癌患者侵袭性疾病风险增加

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2017-01-03

本研究回顾1993至2014年间在75岁及以上接受放疗的前列腺癌患者记录,按PSA检测史分为四组,分析其与NCCN风险分组及活检分级的关系。结果显示,未接受或不完整PSA检测者诊断为高危前列腺癌的比值显著高于接受检测者(OR 3.39,95%CI 1.96-5.87,P<0.001)。作者认为,对可能从早期发现和治疗中获益的健康老年男性考虑筛查是合理的。

要点

  • 接受PSA检测者NCCN高危癌比例为23.0%,未检测或不完整检测者为51.6%(P<0.001)。
  • 多因素分析中,未/不完整PSA检测者高危疾病的OR为3.39(95%CI 1.96-5.87,P<0.001)。
  • 作者认为对可能从早期发现和治疗中获益的健康老年男性考虑筛查是合理的。

核心结论

  • 老年男性未接受PSA检测或不完整检测者,诊断为高危前列腺癌的可能性显著高于既往接受筛查者。
  • 作者认为,对可能从早期发现和治疗中获益的健康老年男性考虑筛查是合理的。

研究设计与样本

  • 回顾性分析1993至2014年期间在75岁及以上接受前列腺癌放疗的男性记录。
  • 符合研究标准的290例受试者中,274例(94.5%)有PSA检测史资料。
  • 按PSA检测史分为四组:未检测、不完整/无效检测、检测、无法确定。
  • 采用多因素logistic回归分析PSA检测史与高危癌的关联。

主要发现

  • 148例(54.0%)接受PSA检测并进行了后续活检,72例(26.3%)接受PSA检测但无适当随访,54例(19.7%)未接受PSA检测。
  • 接受PSA检测者诊断为NCCN高危癌的比例为23.0%,未检测或不完整检测者为51.6%(P<0.001)。
  • 多因素分析中,与接受检测人群相比,未/不完整PSA检测者诊断时高危疾病的OR为3.39(95%CI 1.96-5.87,P<0.001)。

关键数值与推荐

  • NCCN风险分组分为低危、中危和高危。
  • 高危癌比例:接受PSA检测者23.0% vs 未检测或不完整检测者51.6%(P<0.001)。
  • 高危疾病OR 3.39(95%CI 1.96-5.87,P<0.001),对象为未/不完整PSA检测者,对照为接受检测人群。

临床怎么用

  • 作者认为,对可能从早期发现和治疗中获益的健康老年男性考虑筛查是合理的。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the relationship between PSA testing history and high-risk disease among older men diagnosed with prostate cancer. METHODS: Records from 1993 to 2014 were reviewed for men who underwent radiotherapy for prostate cancer at age 75 years or older. Patients were classified into one of four groups based on PSA-testing history: (1) no PSA testing; (2) incomplete/ineffective PSA testing; (3) PSA testing; or (4) cannot be determined. Outcomes of interest were National Comprehensive Cancer Network (NCCN) risk group (that is, low, intermediate or high risk) and biopsy grade at diagnosis. Multivariable logistic regression was used to determine the association between PSA testing history and high-risk cancer. RESULTS: PSA-testing history was available in 274 (94.5%) of 290 subjects meeting study criteria. In total, 148 men (54.0%) underwent PSA testing with follow-up biopsy, 72 (26.3%) underwent PSA testing without appropriate follow-up, and 54 men (19.7%) did not undergo PSA testing. Patients who underwent PSA testing were significantly less likely to be diagnosed with NCCN high-risk cancer (23.0% vs 51.6%, P<0.001). On multivariable analysis, men with no/incomplete PSA testing had more than three-fold increased odds of high-risk disease at diagnosis (odds ratio 3.39, 95% confidence interval 1.96-5.87, P<0.001) as compared to the tested population. CONCLUSIONS: Older men who underwent no PSA testing or incomplete testing were significantly more likely to be diagnosed with high-risk prostate cancer than those who were previously screened. It is reasonable to consider screening in healthy older men likely to benefit from early detection and treatment.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Tosoian JJ, Alam R, Gergis C, et al. Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease. Prostate Cancer Prostatic Dis. 2017. PMID: 28045113. doi:10.1038/pcan.2016.64

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。